The role of early and sufficient isolated venovenous ultrafiltration in heart failure patients with pulmonary and systemic congestion

Reviews in Cardiovascular Medicine

Volumn 14, Issue 2-4, 2013, Pages

  Costanzo, Maria Rosa ^a   Chawla, L S ^b   Tumlin, J A ^c   Herzog, C A ^d   McCullough, Peter A ^e,f   Kellum, J A ^g   Ronco, C ^h  

^a Midwest Heart Specialists   (United States)

^b GEORGE WASHINGTON UNIVERSITY MEDICAL CENTER   (United States)

^c UNIVERSITY OF TENNESSEE COLLEGE OF MEDICINE   (United States)

^d UNIVERSITY OF MINNESOTA MEDICAL SCHOOL   (United States)

^e St John Providence Health System   (United States)

^f PROVIDENCE HOSPITAL   (United States)

^g UNIVERSITY OF PITTSBURGH SCHOOL OF MEDICINE   (United States)

^h SAN BORTOLO HOSPITAL   (Italy)

Author keywords

Cardiorenal syndrome; Diuretics; Heart failure; Ultrafiltration

Indexed keywords

BIOLOGICAL MARKER; DIURETIC AGENT; LOOP DIURETIC AGENT;

ACUTE HEART FAILURE; AUTOREGULATION; BLOOD VOLUME; CARDIORENAL SYNDROME; DRUG MEGADOSE; EXTRACELLULAR FLUID; HEART FAILURE; HUMAN; HYPERVOLEMIA; INTRAVASCULAR SPACE; KIDNEY BLOOD FLOW; LUNG CONGESTION; MACULA DENSA; MORBIDITY; MORTALITY; PATIENT SELECTION; PILOT STUDY; RENIN RELEASE; REVIEW; ULTRAFILTRATION;

ADMINISTRATION, INTRAVENOUS; BLOOD VOLUME; CARDIO-RENAL SYNDROME; DIURETICS; HEART FAILURE; HEMODYNAMICS; HEMOFILTRATION; HUMANS; KIDNEY; PATIENT SELECTION; PULMONARY EDEMA; RISK FACTORS; TIME FACTORS; TREATMENT OUTCOME; WATER-ELECTROLYTE IMBALANCE;

EID: 84893099211     PISSN: 15306550     EISSN: None     Source Type: Journal    
DOI: 10.3909/ricm0685     Document Type: Review

References (48)

1. Dickstein K, Cohen-Solal A, Filippatos G, et al ESC Committee for Practice Guidelines (CPG). ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure 2008: the Task Force for the Diagnosis and Treatment of Acute and Chronic Heart Failure 2008 of the European Society of Cardiology. Developed in collaboration with the Heart Failure Association of the ESC (HFA) and endorsed by the European Society of Intensive Care Medicine (ESICM). Eur Heart J. 2008;29:2388-2442.
2. Nohria A, Tsang SW, Fang JC, et al. Clinical assessment identifies hemodynamic profiles that predict outcomes in patients admitted with heart failure. J Am Coll Cardiol. 2003;41:1797-1804. (Pubitemid 36584255)
3. Bram B, Cupples WA, Joles JA, Gaillard C. Systemic arterial and venous determinants of renal hemodynamics in congestive heart failure. Heart Fail Rev. 2012;17:161-175.
4. Heywood JT, Fonarow GC, Costanzo MR, et al ADHERE Scientific Advisory Committee and Investigators. High prevalence of renal dysfunction and its impact on outcome in 118,465 patients hospitalized with acute decompensated heart failure: a report from the ADHERE database. J Card Fail. 2007;13:422-430. (Pubitemid 47179911)
5. Gheorghiade M, Gattis WA, O'Connor CM, et al Acute and Chronic Therapeutic Impact of a Vasopressin Antagonist in Congestive Heart Failure (ACTIV in CHF) Investigators. Effects of tolvaptan, a vasopressin antagonist, in patients hospitalized with worsening heart failure: a randomized controlled trial. JAMA. 2004;291:1963-1971.
6. Schlatter E, Salomonsson M, Persson AE, Greger R. Macula densa cells sense luminal NaCl concentration via furosemide sensitive Na+2Cl-K+ cotransport. Pflugers Arch. 1989;414:286-290.
7. Felker GM, Lee KL, Bull DA, et al NHLBI Heart Failure Clinical Research Network. Diuretic strategies in patients with acute decompensted heart failure. N Engl J Med. 2011;364:797-805.
8. Costanzo MR, Jessup M. Treatment of congestion in heart failure with diuretics and extracorporeal therapies: effects on symptoms, renal function, and prognosis. Heart Fail Rev. 2012;17:313-324.
9. Ronco C, Ricci Z, Bellomo R, Bedogni F. Extacorporeal ultrafiltration for the treatment of overhydration and congestive heart failure. Cardiology. 2001;96: 155-168. (Pubitemid 34114125)
10. Jaski BE, Ha J, Denys BG, et al. Peripherally inserted veno-venous ultrafiltration for rapid treatment of volume overloaded patients. J Card Fail. 2003;9:227-231. (Pubitemid 36734320)
11. Ronco C, Haapio M, House AA, et al. Cardiorenal syndrome. J Am Coll Cardiol. 2008;52:1527-1539.
12. Kellum JA, Bellomo R, Ronco C. Acute Dialysis Quality Initiative (ADQI): methodology. Int J Artif Organs. 2008;31:90-93. (Pubitemid 351425006)
13. Costanzo MR, Saltzberg M, O'Sullivan J, Sobotka P. Early ultrafiltration in patients with decompensated heart failure and diuretic resistance. J Am Coll Cardiol. 2005;46:2047-2051. (Pubitemid 41713590)
14. Agostoni P, Marenzi G, Lauri G, et al. Sustained improvement in functional capacity after removal of body fluid with isolated ultrafiltration in chronic cardiac insufficiency: failure of furosemide to provide the same result. Am J Med. 1994;96:191-199.
15. Bart BA, Boyle A, Bank AJ, et al. Ultrafiltration versus usual care for hospitalized patients with heart failure: the Relief for Acutely Fluid-Overloaded Patients With Decompensated Congestive Heart Failure (RAPIDCHF) trial. J Am Coll Cardiol. 2005;46:2043-2046. (Pubitemid 41713589)
16. Liang KV, Hiniker AR, Wiliams AW, et al. Use of a novel ultrafiltration device as a treatment strategy for diuretic resistant, refractory heart failure: initial clinical experience in a single center. J Cardiac Fail. 2006;12:707-714. (Pubitemid 44889284)
17. Rose EA, Gelijins AC, Moskowitz AJ, et al Randomized Evaluation of Mechanical Assistance for the Treatment of Congestive Heart Failure (REMATCH) Study Group. Long-term use of a left ventricular assist device for end-stage heart failure. N Engl J Med. 2001;345:1435-1443.
18. Cipolla CM, Grazi S, Rimondini A, et al. Changes in circulating norepinephrine with hemofiltration in advanced heart failure. Am J Cardiol. 1990;66:987-994. (Pubitemid 20360594)
19. Marenzi G, Grazi S, Giraldi F, et al. Interrelation of humoral factors, hemodynamics, and fluid and salt metabolism in congestive heart failure: effects of extracorporeal ultrafiltration. Am J Med. 1993;94:49-56. (Pubitemid 23021171)
20. Costanzo MR, Guglin ME, Saltzberg MT, et al UNLOAD Trial Investigators. Ultrafiltration versus intravenous diuretics for patients hospitalized for acute decompensated heart failure. J Am Coll Cardiol. 2007;49:675-683. (Pubitemid 46205043)
21. Elkayam U, Hatamizadeh P, Janmohamed M. The challenge of correcting volume overload in hospitalized patients with decompensated heart failure. J Am Coll Cardiol. 2007;49:684-686.
22. Costanzo MR, Saltzberg MT, Jessup M, et al Ultrafiltration Versus Intravenous Diuretics for Patients Hospitalized for Acute Decompensated Heart Failure (UNLOAD) Investigators. Ultrafiltration is associated with fewer re-hospitalizations than continuous diuretic infusion in patients with decompensated heart failure: results from UNLOAD. J Card Fail. 2010;16:277-284.
23. Ali SS, Olinger CC, Sobotka PA, et al. Loop diuretics can cause clinical natriuretic failure: a prescription for volume expansion. Congest Heart Fail. 2009;15:1-4.
24. Konstam MA, Gheorghiade M, Burnett JC Jr, et al Efficacy of Vasopressin Antagonism in Heart Failure Outcome Study With Tolvaptan (EVEREST) Investigators. Effects of oral tolvaptan in patients hospitalized for worsening heart failure: the EVEREST Outcome Trial. JAMA. 2007;297:1319-1331. (Pubitemid 46513233)
25. Abdallah JG, Schreier RW, Edelstein C, et al. Loop diuretic infusion increases thiazide-sensitive Na(+)/Cl(-)-cotransporter abundance: role of aldosterone. J Am Soc Nephrol. 2001;12:1335-1341. (Pubitemid 32666316)
26. Mullens W, Abrahams Z, Francis GS, et al. Importance of venous congestion for worsening of renal function in advanced decompensated heart failure. J Am Coll Cardiol. 2009;53:589-596.
27. Jessup M, Costanzo MR. The cardiorenal syndrome: do we need a change of strategy or a change of tactics? J Am Coll Cardiol. 2009;53:597-599.
28. Ross EA. Congestive heart failure: the pathophysiology and treatment of renal venous hypertension. J Cardiac Fail. 2012;18:930-938.
29. Bart BA, Goldsmith SR, Lee KL, et al Heart Failure Clinical Research Network. Ultrafiltration in decompensated heart failure with cardiorenal syndrome. N Engl J Med. 2012:367:2296-2304.
30. Bart BA, Goldsmith SR, Lee KL, et al. Cardiorenal rescue study in acute decompensated heart failure: rationale and design of CARRESS-HF, for the Heart Failure Clinical Research Network. J Cardiac Fail. 2012;18:176-182.
31. Testani JM, Chen J, McCauley BD, et al. Potential effects of aggressive decongestion during the treatment of decompensated heart failure on renal function and survival. Circulation. 2010;122:265-272.
32. Bartone C, Saghir S, Menon SG, et al. Comparison of ultrafiltration, nesiritide, and usual care in acute decompensated heart failure. Congest Heart Fail. 2008;14:298-301.
33. Patarroyo M, Wehbe E, Hanna M, et al. Cardiorenal outcomes after slow continuous ultrafiltration therapy in refractory patients with advanced decompensated heart failure. J Am Coll Cardiol. 2012;60:1906-1912.
34. Dev S, Shirolkar SC, Stevens SR, et al. Reduction in body weight but worsening renal function with late ultrafiltration for treatment of acute decompensated heart failure. Cardiology. 2012;123:145-153.
35. Costanzo MR, Ronco C. Isolated ultrafiltration in heart failure patients. Curr Cardiol Rep. 2012;14: 254-264.
36. Singh P, Rifkin DE, Blantz RC. Chronic kidney disease: an inherent risk factor for acute kidney injury? Clin J Am Soc Nephrol. 2010;5:1690-1695.
37. Tang WH. Reconsidering ultrafiltration in the acute cardiorenal syndrome. N Engl J Med. 2012;367: 2351-2352.
38. Jessup M, Abraham WT, Casey DE, et al. 2009 focused update: ACCF/AHA Guidelines for the Diagnosis and Management of Heart Failure in Adults: a report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines: developed in collaboration with the International Society for Heart and Lung Transplantation. Circulation. 2009;119:1977-2016.
39. Gheorghiade M, Follath F, Ponikowski P, et al. Assessing and grading congestion in acute heart failure: a scientific statement from the acute heart failure committee of the heart failure association of the European Society of Cardiology and endorsed by the European Society of Intensive Care Medicine. Eur J Heart Fail. 2010;12:423-433.
40. Marenzi G, Lauri G, Grazi M, et al. Circulatory response to fluid overload removal by extracorporeal ultrafiltration in refractory congestive heart failure. J Am Coll Cardiol. 2001;38:963-968. (Pubitemid 32912695)
41. Stawicki SP, Braslow BM, Panebianco NL, et al. Intensivist use of hand-carried ultrasonography to measure IVC collapsibility in estimating intravascular volume status: correlation with CVP. J Am Coll Surg. 2009;209:55-61.
42. Ronco C, Brendolan A, Bellomo R. Online monitoring in continuous renal replacement therapies. Kidney Int. 1999;56(suppl):S8-S14.
43. Maisel AS, Krishnaswamy P, Nowak RM, et al Breathing Not Properly Multinational Study Investigators. Rapid measurement of B-type natriuretic peptide in the emergency diagnosis of heart failure. N Eng J Med. 2002;347:161-167. (Pubitemid 34764819)
44. Logeart D, Thabut G, Jourdain P, et al. Predischarge Btype natriuretic peptide assay for identifying patients at high risk of re-admission after decompensated heart failure. J Am Coll Cardiol. 2004;43:635-641. (Pubitemid 38229537)
45. Piccoli A, Nigelli S, Caberlotto A, et al. Bivariate normal values of the bioelectrical impedance vector in adult and elderly populations. Am J Clin Nutr. 1995;61:269-270.
46. Piccoli A. Whole body-single frequency bioimpedance. Contrib Nephrol. 2005;149:150-161.
47. Ronco C, Kaushik M, Valle R, et al. Diagnosis and management of fluid overload in heart failure and the cardio-renal syndrome: the "5B" approach. Semin Nephrol. 2012;32:129-141.
48. Costanzo MR, Cozzolino M, Aspromonte N, et al. Extracorporeal ultrafiltration in heart failure and cardiorenal syndromes. Semin Nephrol. 2012;32:100-111.